Home Newsfeeds Wolfe Research Initiates Coverage On Cousins Props with Peer Perform Rating

Wolfe Research Initiates Coverage On Cousins Props with Peer Perform Rating

Wolfe Research analyst Andrew Rosivach initiates coverage on Cousins Props (NYSE:CUZ) with a Peer Perform rating.

byBenzinga Newsdesk

July 1, 2022

1 minute read

Wolfe Research analyst Andrew Rosivach initiates coverage on Cousins Props (NYSE:CUZ) with a Peer Perform rating.

Apple To Rally 15%? Here Are 10 Other Analyst Forecasts For Wednesday

By Lisa Levin

April 19, 9:14 AM

Morgan Stanley raised the price target for Align Technology, Inc. (NASDAQ: ALGN) from $314 to $383. Morgan Stanley analyst Erin Wright maintained an Overweight rating. Align Technology shares fell 0.9% to $345.00 in pre-market trading.

AAPL

Guggenheim Maintains Buy on NextEra Energy, Raises Price Target to $108

By Benzinga Newsdesk

September 12, 9:32 AM

Guggenheim analyst Shahriar Pourreza maintains NextEra Energy (NYSE:NEE) with a Buy and raises the price target from $91 to $108.

NEE

Senti Bio Announces New Strategic Collaboration With Celest Therapeutics For Clinical Development Of SENTI-301A In China; Senti Bio Eligible To Receive Up To $156M In Milestones And Royaltie

By Benzinga Newsdesk

November 6, 5:41 PM

– Celest to lead clinical development with technical support from Senti Bio – – First patient expected to be enrolled in China in 1H 2024 –– Senti Bio eligible to receive up to $156 million in milestones and

SNTI